National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings, 14574 [E9-7197]
Download as PDF
<![CDATA[
14574
Federal Register / Vol. 74, No. 60 / Tuesday, March 31, 2009 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
tjames on PRODPC61 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Regulation of Cytokine
Transcription and Inflammation.
Date: March 30, 2009.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817,
(Telephone Conference Call).
Contact Person: Jay Bruce Sundstrom, PhD,
Scientific Review Officer, Scientific Review
Program, DEA/NIAID/NIH/DHHS, Room
3119, 6700B Rockledge Drvie, MSC–7616,
Bethesda, MD 20892–7616, 301–496–7042,
sundstromj@niaid.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; B Cell Epitope Discovery
and Mechanisms of Antibody Protection.
Date: April 20–21, 2009.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate contract
proposals.
Place: The Legacy Hotel and Meeting
Centre, 1775 Rockville Pike, Rockville, MD
20852.
Contact Person: Quirijn Vos, PhD,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
NIH/NIAID/DHHS, 6700B Rockledge Drive,
MSC 7616, Bethesda, MD 20892, 301–451–
2666, qvos@niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Rapid HIV Point-of-Care
Diagnostic Device for Resource-Limited
Setting.
Date: April 20–21, 2009.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate contract
proposals.
VerDate Nov<24>2008
14:35 Mar 30, 2009
Jkt 217001
Place: Doubletree Hotel and Executive
Meeting Center, 8120 Wisconsin Ave,
Bethesda, MD 20814.
Contact Person: Roberta Binder, PhD,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
NIAID/NIH/DHHS, 6700B Rockledge Drive,
MSC 7616, Room 3130, Bethesda, MD 20892–
7616, 301–496–7966, rbinder@niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Ancillary Studies in
Immunomodulation Clinical Trials.
Date: April 24, 2009.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817,
(Telephone Conference Call).
Contact Person: Paul A. Amstad, PhD,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
NIAID/NIH/DHHS, 6700B Rockledge Drive,
MSC 7616, Bethesda, MD 20892–7616, 301–
402–7098, pamstad@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: March 25, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–7197 Filed 3–30–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
Scientific Management Review Board.
The NIH Reform Act of 2006 (Pub. L.
109–482) provides organizational
authorities to HHS and NIH officials to:
(1) Establish or abolish national research
institutes; (2) reorganize the offices
within the Office of the Director, NIH,
including adding, removing, or
transferring the functions of such offices
or establishing or terminating such
offices; and (3) reorganize, divisions,
centers, or other administrative units
within an NIH national research
institute or national center including
adding, removing, or transferring the
functions of such units, or establishing
or terminating such units. The purpose
of the Scientific Management Review
Board (also referred to as SMRB or
Board) is to advise appropriate HHS and
NIH officials on the use of these
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
organizational authorities and identify
the reasons underlying the
recommendations.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Scientific
Management Review Board.
Date: April 27–28, 2009.
Open: April 27, 2009, 8:30 a.m. to 5:30
p.m.
Agenda: Presentation and discussion will
include an overview of NIH mission,
structure, budget, perspectives on how
science has shaped the NIH organization, and
future directions. There will also be time
allotted on the agenda for public comment.
Sign up for public comment will begin at
approximately 8 a.m. on both April 27 and
28. In the event that time does not allow for
all those interested to present oral comments,
anyone may file written comments using the
address below.
Place: National Institutes of Health,
Building 31, 6th Floor, Conference Room 6,
31 Center Drive, Bethesda, MD 20892.
Open: April 28, 2009, 8:30 a.m. to 3:30
p.m.
Agenda: Continuation of April 27th
meeting.
Place: National Institutes of Health,
Building 31, 6th Floor, Conference Room 6,
31 Center Drive, Bethesda, MD 20892.
Contact Person: Dr. Lyric Jorgenson, PhD,
NIH–AAAS Science and Technology Policy
Fellow, Office of Science Policy, Office of the
Director, NIH, National Institutes of Health,
Building 1 Room 218 MSC 0166, 9000
Rockville Pike, Bethesda, MD 20892.
smrb@mail.nih.gov. (301) 496–6837.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
The meeting will also be Web cast. The
draft meeting agenda and other information
about the SMRB, including information about
access to the Web cast, will be available at
https://smrb.od.nih.gov.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Dated: March 25, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–7200 Filed 3–30–09; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\31MRN1.SGM
31MRN1
]]>Agencies
[Federal Register Volume 74, Number 60 (Tuesday, March 31, 2009)]
[Notices]
[Page 14574]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-7197]
[[Page 14574]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Regulation of Cytokine
Transcription and Inflammation.
Date: March 30, 2009.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6700B Rockledge Drive,
Bethesda, MD 20817, (Telephone Conference Call).
Contact Person: Jay Bruce Sundstrom, PhD, Scientific Review
Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, Room 3119,
6700B Rockledge Drvie, MSC-7616, Bethesda, MD 20892-7616, 301-496-
7042, sundstromj@niaid.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; B Cell Epitope Discovery and
Mechanisms of Antibody Protection.
Date: April 20-21, 2009.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate contract proposals.
Place: The Legacy Hotel and Meeting Centre, 1775 Rockville Pike,
Rockville, MD 20852.
Contact Person: Quirijn Vos, PhD, Scientific Review Officer,
Scientific Review Program, Division of Extramural Activities, NIH/
NIAID/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892,
301-451-2666, qvos@niaid.nih.gov.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Rapid HIV Point-of-Care Diagnostic
Device for Resource-Limited Setting.
Date: April 20-21, 2009.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate contract proposals.
Place: Doubletree Hotel and Executive Meeting Center, 8120
Wisconsin Ave, Bethesda, MD 20814.
Contact Person: Roberta Binder, PhD, Scientific Review Officer,
Scientific Review Program, Division of Extramural Activities, NIAID/
NIH/DHHS, 6700B Rockledge Drive, MSC 7616, Room 3130, Bethesda, MD
20892-7616, 301-496-7966, rbinder@niaid.nih.gov.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Ancillary Studies in
Immunomodulation Clinical Trials.
Date: April 24, 2009.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6700B Rockledge Drive,
Bethesda, MD 20817, (Telephone Conference Call).
Contact Person: Paul A. Amstad, PhD, Scientific Review Officer,
Scientific Review Program, Division of Extramural Activities, NIAID/
NIH/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892-7616,
301-402-7098, pamstad@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: March 25, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-7197 Filed 3-30-09; 8:45 am]
BILLING CODE 4140-01-P
